New App Could Monitor Disease Progression Simply by Recording Patient’s Speech

A team of cross-disciplinary researchers at Arizona State University (ASU) is working to develop a software which patients with neurological disorders may easily use to assess their disease progression. Through…

Continue Reading New App Could Monitor Disease Progression Simply by Recording Patient’s Speech
XLA: This Father Helped Identify the Disease That Killed His First-Born Son—and Saved His Youngest in the Process
source: pixabay.com

XLA: This Father Helped Identify the Disease That Killed His First-Born Son—and Saved His Youngest in the Process

According to a story from USA Today, Thanksgiving 2009 was a harrowing time for the Anderson family. About a month earlier, Darrin and Sarah Anderson's oldest son Henry had died…

Continue Reading XLA: This Father Helped Identify the Disease That Killed His First-Born Son—and Saved His Youngest in the Process
Muscular Dystrophy Association’s Pompe Disease Patient Focused Drug Development Meeting Cleared by FDA
source: pixabay.com

Muscular Dystrophy Association’s Pompe Disease Patient Focused Drug Development Meeting Cleared by FDA

According to a story from tradeshownews.vporoom.com, the Muscular Dystrophy Association (MDA) has recently announced the official approval of its Patient-Focused Drug Development (PFDD) meeting by the US Food and Drug…

Continue Reading Muscular Dystrophy Association’s Pompe Disease Patient Focused Drug Development Meeting Cleared by FDA
The FDA Approves New Treatment for Chronic Lymphocytic Leukemia Under an International Program
source: pixabay.com

The FDA Approves New Treatment for Chronic Lymphocytic Leukemia Under an International Program

According to a story from PR Newswire, the US Food and Drug Administration (FDA) has recently granted supplemental approval to the drug acalabrutinib (marketed as Calquence) as a treatment for…

Continue Reading The FDA Approves New Treatment for Chronic Lymphocytic Leukemia Under an International Program
“We Don’t Know Anything:” a Mitochondrial Encephalomyopathy Story From the Czech Republic
source: pixabay.com

“We Don’t Know Anything:” a Mitochondrial Encephalomyopathy Story From the Czech Republic

When Lucinka was born, it seemed like everything was all right. But it wasn’t. Lucinka wasn’t doing well, and a whirlwind of examinations began. First, a diagnosis couldn’t be made.…

Continue Reading “We Don’t Know Anything:” a Mitochondrial Encephalomyopathy Story From the Czech Republic

Her Baby’s SLC6A1 Genetic Disorder is Currently Untreatable, But Amber Freed is Committed to Finding a Cure

  Amber’s determination to find a miracle for her son Maxwell is detailed in a recent BuzzFeed article. Maxwell and his twin sister, Riley, were born in March 2017. For…

Continue Reading Her Baby’s SLC6A1 Genetic Disorder is Currently Untreatable, But Amber Freed is Committed to Finding a Cure
The Drug Tofacitinib Appears Effective for Juvenile Idiopathic Arthritis in Clinical Trial
source: pixabay.com

The Drug Tofacitinib Appears Effective for Juvenile Idiopathic Arthritis in Clinical Trial

According to a story from Juvenile Arthritis News, the results of a recent phase 3 clinical trial indicate that the drug tofacitinib (marketed as Xeljanz) can be an effective treatment…

Continue Reading The Drug Tofacitinib Appears Effective for Juvenile Idiopathic Arthritis in Clinical Trial